NewsRx

Search our medical news database

Appointments

Lipid Sciences announces board and management changes

Published in AIDS Weekly, December 16th, 2002

Lipid Sciences, Inc., (LIPD) has announced several changes to its board of directors and management.

Phil Radlick, PhD, has resigned as president and CEO and as a director of the company. He will continue on as a consultant to the company.

In addition, chairman Richard G. Babbitt and board members S. Lewis Meyer, PhD, and Frank M. Placenti have been appointed to a newly created executive committee of the board of directors. Former chairman Christopher A. Marlett also has resigned as a director of the company. The board of directors has commenced a search for new director candidates.

The company has retained an executive search...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook